Effect of Vitamin D Supplementation on Uterine Fibroid size

Evaluation of the Effect of Vitamin D Supplementation on Uterine Fibroid size in Women Attending Fatemieh Hospital in Hamadan

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230522058253N11

Enrollment

230

Registered

2026-04-13

Start date

2025-11-21

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Vitamin D Supplementation on Uterine Fibroid size. Cystic fibrosis

Interventions

Intervention 1: Intervention group : serum level of vitamin d was measured by elisa and Uterine Fibroid characteristics ( mm ) , number , location and sonography of the fatemieh hospital were evaluat

none of the subjects had prior experience of this supplement , but in the intervention group , vitamin d supplements were used daily for 12 weeks .after the intervention ( 12 weeks ) , as well as befo

none of the subjects had prior experience of this supplement in the control group .after the intervention ( 12 weeks ) , as well as before the intervention in both groups to determine the serum level

Eligibility

Sex/Gender

Female

Age

20 Years to 52 Years

Inclusion criteria

Inclusion criteria: The patients with UF diagnosis with a marked and asymptomatic period. Ages 20 to 52.

Exclusion criteria

Exclusion criteria: Women who had one or more of the following conditions in their medical record were excluded from the study : having disease such as diabetes , heart disease , asthma , thrombolytic therapy , inflammatory bowel disease , previous hysterectomy .suspicious , menopause , malignancy , blood pressure , diabetes , autoimmune , liver or kidney disorders.

Design outcomes

Primary

Measure	Time frame
Reducing the size of Uterine Fibroid after consumption of vitamin d supplement. Timepoint: 12 weeks after consumption of vitamin d supplement , the size of Uterine Fibroid was measured and compared before the intervention . Method of measurement: In the supplement group , vitamin d 1000 u was used daily for 12 weeks and the control group received no supplement .after the intervention ( 12 weeks ) , as well as before the intervention in both groups to determine the serum level of 25 hydro - vitamin d , which was active form of vitamin d , was measured in the laboratory of fatemieh hospital or primary referral lab .ultrasound examination of the patients was done after trail and the number of Uterine Fibroid was measured again .	—

Measure

Time frame

Reducing the size of Uterine Fibroid after consumption of vitamin d supplement. Timepoint: 12 weeks after consumption of vitamin d supplement , the size of Uterine Fibroid was measured and compared before the intervention . Method of measurement: In the supplement group , vitamin d 1000 u was used daily for 12 weeks and the control group received no supplement .after the intervention ( 12 weeks ) , as well as before the intervention in both groups to determine the serum level of 25 hydro - vitamin d , which was active form of vitamin d , was measured in the laboratory of fatemieh hospital or primary referral lab .ultrasound examination of the patients was done after trail and the number of Uterine Fibroid was measured again .

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Alimohammadi

Hamedan University of Medical Sciences

nalimohamadi68@yahoo.com+98 81 3838 0808

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026